Salasar Techno Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 15, 2025, 11:51 am

Competitors of Salasar Techno Engineering Ltd

All Competitor Stocks of Salasar Techno Engineering Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:54 am

Below is a detailed analysis of the quarterly data for Salasar Techno Engineering Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 483.31 Cr.. The value appears strong and on an upward trend. It has increased from 375.18 Cr. (Dec 2024) to 483.31 Cr., marking an increase of 108.13 Cr..
• For Expenses, as of Mar 2025, the value is 455.86 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 343.46 Cr. (Dec 2024) to 455.86 Cr., marking an increase of 112.40 Cr..
• For Operating Profit, as of Mar 2025, the value is 27.45 Cr.. The value appears to be declining and may need further review. It has decreased from 31.72 Cr. (Dec 2024) to 27.45 Cr., marking a decrease of 4.27 Cr..
• For OPM %, as of Mar 2025, the value is 5.68%. The value appears to be declining and may need further review. It has decreased from 8.45% (Dec 2024) to 5.68%, marking a decrease of 2.77%.
• For Other Income, as of Mar 2025, the value is -3.91 Cr.. The value appears to be declining and may need further review. It has decreased from 0.71 Cr. (Dec 2024) to -3.91 Cr., marking a decrease of 4.62 Cr..
• For Interest, as of Mar 2025, the value is 13.86 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.08 Cr. (Dec 2024) to 13.86 Cr., marking an increase of 0.78 Cr..
• For Depreciation, as of Mar 2025, the value is 4.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.09 Cr. (Dec 2024) to 4.74 Cr., marking an increase of 1.65 Cr..
• For Profit before tax, as of Mar 2025, the value is 4.94 Cr.. The value appears to be declining and may need further review. It has decreased from 16.26 Cr. (Dec 2024) to 4.94 Cr., marking a decrease of 11.32 Cr..
• For Tax %, as of Mar 2025, the value is 206.07%. The value appears to be increasing, which may not be favorable. It has increased from 26.51% (Dec 2024) to 206.07%, marking an increase of 179.56%.
• For Net Profit, as of Mar 2025, the value is -5.23 Cr.. The value appears to be declining and may need further review. It has decreased from 11.94 Cr. (Dec 2024) to -5.23 Cr., marking a decrease of 17.17 Cr..
• For EPS in Rs, as of Mar 2025, the value is -0.03. The value appears to be declining and may need further review. It has decreased from 0.07 (Dec 2024) to -0.03, marking a decrease of 0.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:15 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:25 am

Below is a detailed analysis of the balance sheet data for Salasar Techno Engineering Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 173.00 Cr.. The value appears strong and on an upward trend. It has increased from 158.00 Cr. (Mar 2024) to 173.00 Cr., marking an increase of 15.00 Cr..
• For Reserves, as of Mar 2025, the value is 613.00 Cr.. The value appears strong and on an upward trend. It has increased from 292.00 Cr. (Mar 2024) to 613.00 Cr., marking an increase of 321.00 Cr..
• For Borrowings, as of Mar 2025, the value is 317.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 350.00 Cr. (Mar 2024) to 317.00 Cr., marking a decrease of 33.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 622.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 351.00 Cr. (Mar 2024) to 622.00 Cr., marking an increase of 271.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,725.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,151.00 Cr. (Mar 2024) to 1,725.00 Cr., marking an increase of 574.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 394.00 Cr.. The value appears strong and on an upward trend. It has increased from 239.00 Cr. (Mar 2024) to 394.00 Cr., marking an increase of 155.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,330.00 Cr.. The value appears strong and on an upward trend. It has increased from 912.00 Cr. (Mar 2024) to 1,330.00 Cr., marking an increase of 418.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,725.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,151.00 Cr. (Mar 2024) to 1,725.00 Cr., marking an increase of 574.00 Cr..

Notably, the Reserves (613.00 Cr.) exceed the Borrowings (317.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Salasar Techno Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.34 (Mar 24) to 0.11, marking a decrease of 0.23.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.34 (Mar 24) to 0.11, marking a decrease of 0.23.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 3. It has decreased from 0.40 (Mar 24) to 0.22, marking a decrease of 0.18.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.55. It has increased from 2.86 (Mar 24) to 4.55, marking an increase of 1.69.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.55. It has increased from 2.86 (Mar 24) to 4.55, marking an increase of 1.69.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 8.38. It has increased from 7.66 (Mar 24) to 8.38, marking an increase of 0.72.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 2. It has decreased from 0.79 (Mar 24) to 0.69, marking a decrease of 0.10.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.73 (Mar 24) to 0.58, marking a decrease of 0.15.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.45 (Mar 24) to 0.22, marking a decrease of 0.23.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 2. It has decreased from 0.33 (Mar 24) to 0.11, marking a decrease of 0.22.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.11. This value is below the healthy minimum of 2. It has decreased from 0.33 (Mar 24) to 0.11, marking a decrease of 0.22.
• For PBDIT Margin (%), as of Mar 25, the value is 8.27. This value is below the healthy minimum of 10. It has decreased from 10.41 (Mar 24) to 8.27, marking a decrease of 2.14.
• For PBIT Margin (%), as of Mar 25, the value is 6.93. This value is below the healthy minimum of 10. It has decreased from 9.57 (Mar 24) to 6.93, marking a decrease of 2.64.
• For PBT Margin (%), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 10. It has decreased from 5.96 (Mar 24) to 2.73, marking a decrease of 3.23.
• For Net Profit Margin (%), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 5. It has decreased from 4.38 (Mar 24) to 1.32, marking a decrease of 3.06.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 8. It has decreased from 4.38 (Mar 24) to 1.31, marking a decrease of 3.07.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 15. It has decreased from 11.75 (Mar 24) to 2.43, marking a decrease of 9.32.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.08. This value is within the healthy range. It has decreased from 23.03 (Mar 24) to 12.08, marking a decrease of 10.95.
• For Return On Assets (%), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 5. It has decreased from 4.59 (Mar 24) to 1.10, marking a decrease of 3.49.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.02, marking a decrease of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.40. This value is within the healthy range. It has decreased from 0.77 (Mar 24) to 0.40, marking a decrease of 0.37.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has decreased from 1.17 (Mar 24) to 1.01, marking a decrease of 0.16.
• For Current Ratio (X), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 1.5. It has increased from 1.35 (Mar 24) to 1.42, marking an increase of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 1.04, marking an increase of 0.22.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.46. This value is below the healthy minimum of 4. It has increased from 2.69 (Mar 24) to 3.46, marking an increase of 0.77.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 3. It has decreased from 2.88 (Mar 24) to 2.31, marking a decrease of 0.57.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.54. This value is below the healthy minimum of 3. It has decreased from 2.21 (Mar 24) to 1.54, marking a decrease of 0.67.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,688.19. It has decreased from 3,478.42 (Mar 24) to 1,688.19, marking a decrease of 1,790.23.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 2.88 (Mar 24) to 1.17, marking a decrease of 1.71.
• For EV / EBITDA (X), as of Mar 25, the value is 14.09. This value is within the healthy range. It has decreased from 27.63 (Mar 24) to 14.09, marking a decrease of 13.54.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 2.61 (Mar 24) to 0.98, marking a decrease of 1.63.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 1.81. This value is within the healthy range. It has decreased from 7.01 (Mar 24) to 1.81, marking a decrease of 5.20.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 2.61 (Mar 24) to 0.98, marking a decrease of 1.63.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness